FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Clears Ascendx Vertebral Fracture System

[ Price : $8.95]

FDA clears an Ascendx Spine 510(k) for its Ascendx VCF Repair System, intended for use in treating vertebral compression fractures...

Axelrad to be Woodcock Senior Advisor

[ Price : $8.95]

CDER Office of Regulatory Policy director Jane Axelrad is becoming Janet Woodcocks senior advisor to take the FDA lead on drug com...

Boxed Warning Added to Incivek Label

[ Price : $8.95]

Vertex says a Boxed Warning has been added to the Incivek label to highlight the risk of fatal and non-fatal serious skin reaction...

Safety Board Backs Rockwell Iron Replacement Therapy

[ Price : $8.95]

Rockwell Medical says it has received backing from an independent Data Safety Monitoring Board providing oversight for the company...

NEWSROOM CLOSED FOR THE HOLIDAYS

[ Price : $8.95]

FDA Webview has closed its newsroom for the traditional Festive Season holiday break. We will resume normal operations on January ...

FDA Approves Angiotech Biopsy-sealing System

[ Price : $8.95]

FDA grants de novo approval for Angiotechs Bio-Seal Lung Biopsy Tract Plug System, a device that seals punctures left by lung biop...

FDA Sends Info on Emergency Use Authorization to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits to the Office of Management and Budget a proposed collection of information on reporting and ...

Execs, Not FDA, to Blame for Innovation Lag: Pundit

[ Price : $8.95]

Forbes commentator Bernard Munos says drug companies should fix their own problems with drug innovation rather than blaming FDA.

FDA Urged to Bar Generic Opioids that Can be Abused

[ Price : $8.95]

Former FDAer Scott Gottlieb and Sen. Tom Coburn call on FDA to quickly reject generic opioids that are not tamper-resistant.

Amarin Wants Chemport to be Vascepa API Supplier

[ Price : $8.95]

Amarin asks FDA to approve Chemport as an additional API supplier for its Vascepa.